<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">943</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-4-5-6-30-32</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Server lights. Rating of Russian pharmacy chains according to the Q1 2020 results</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bespalov</surname><given-names>Nikolay</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rasshchupkin</surname><given-names>Pavel</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">analytical company RNC Pharma</aff><pub-date date-type="epub" iso-8601-date="2020-12-04" publication-format="electronic"><day>04</day><month>12</month><year>2020</year></pub-date><issue>4-6</issue><fpage>30</fpage><lpage>32</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>The document legalizing the possibility of online drug retail was very lucky: there was an epidemic of coronavirus, self-isolation and boom in the development of remote services. All this made it impossible to further delay the adoption of the document. However, its «opponents» did everything possible to slow down the entry to the market for new players, including the giants of Internet retail. In fact, the process has been launched, but the main battle online is still ahead.</abstract><kwd-group xml:lang="en"><kwd>rating</kwd><kwd>pharmacy chains</kwd><kwd>online retail</kwd><kwd>coronavirus</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рейтинг</kwd><kwd>аптечные сети</kwd><kwd>онлайн-торговля</kwd><kwd>коронавирус</kwd></kwd-group></article-meta></front><body></body><back/></article>
